JosephA.AloiMDFACP, FACE(he/him)

PubMed

• Continuous Glucose Monitoring in Older Adults: What We Know and What We Have Yet to Learn.
  Catherine Price, Kathryn E Callahan, Joseph A Aloi, Chinenye O Usoh
  Journal of Diabetes Science and Technology. 2024-05-01
• 1 citations
  Precision nephrotoxicity testing using 3D in vitro models.
  Pengfei Yu, Hainan Zhu, Carol Christine Bosholm, Daniella Beiner, Zhongping Duan
  Cell & Bioscience. 2023-12-21
• 13 citations
  A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials.
  Elias K Spanakis, Curtiss B Cook, Kristen Kulasa, Joseph A Aloi, Lia Bally
  Journal of Diabetes Science and Technology. 2023-11-01

Journal Articles

• Tides of Change: Improving Glucometrics in a Large Multihospital Health Care System  
  Mulla C, Lieb DC, McFarland R and Aloi JA, Journal of Diabetes Science and Technology, 1/1/2014
• Recombinant Human Parathyroid Hormone Therapy (1-34) in an Adult Patient with a Gain-of-Function Mutation in the Calcium-Sensing Receptor — A Case Report  
  Gonzales Michael C., et al, Endocrine Practice, 1/1/2013
• Role of Glucose Metrics in Global CVD Risk Assessment: Primary and Secondary Populations  
  Aloi JA and Taylor, A, American College of Cardiology Board Review, 1/1/2009
• Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes A 24-week, double-blind, randomized trial  
  Julio Rosenstock, MD, Michelle A. Baron, MD, Sylvie Dejager, MD, PHD, David Mills, MSC and Anja Schweizer, PHD, Diabetes Care, 1/1/2007
• Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily ...  
  Shah N, Aloi J, Evans WS, Veldhuis JD, J Clin Endo Metab, 1/1/1999
• Polycystic ovarian syndrome- Evidence for reduced sensitivity of the GnRH Pulse generator to inhibition by estradiol and progesterone  
  Pastor C, Griffin-Gorf ML, Aloi JA, Evans WS, Marshall JC, J Clin Endo Metab, 1/1/1998
• Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men  
  Bergendahl M, Aloi JA, Iranmanesh A, Mulligan TM, Veldhuis JD, J Clin Endo Metab, 1/1/1998
• Pulsatile GnRH administration averts fasting-induced hypoandrogenemia in healthy, normal weight men  
  Aloi JA, Bergandahl M, Iranamesh A, and Veldhuis JD, J Clin Endo Metab, 1/1/1997
• Ovarian Activin receptor subtype and follistatin gene expression in rats: Reciprocal regulation by gonadotropins  
  Aloi JA, Marshall JC, Yasin M, Gilrain JT, Haisenleder DJ, and Dalkin AC, Biology of Reproduction, 1/1/1997
• Evaluation of Amenorrhea  
  Aloi JA, Comprehensive Therapy, 1/1/1995
• Ovarian inhibin subunit gene expression: Regulation by gonadotropins and estradiol  
  Aloi JA, Dalkin AC, Haisenleder DJ, Yasin M, and Marshal JC, Endocrinology, 1/1/1995
• Neuroendocrine responses to a novel growth hormone secretagogue in healthy older subjects  
  Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, and Thorner MO, J Clin Endo Metab, 1/1/1994
• Ovariectomy and Inhibin immunoneutralization acutely increase FSHbeta mRNA concentrations: Evidence for a nontranscriptional mechanism  
  Dalkin AC, Knight CD, Shupnik MA, Haisenleder DJ, Aloi J, Kirk SE, Yasin M, and Marshall JC, Endocrinology, 1/1/1993
• CSF and endocrine studies of Premenstrual Syndrome  
  Parry BL, Gerner R, Wilkins JN, Halaris AE, Carlson HE, Hershman JH, Linnoila M, Merrill J, Gold PW, Gracely R, Aloi JA, Newton R, Neuropsycholopharmacology, 1/1/1991
• Tetrahydrobiopterin administration to Rheusus Macaques: Its appearance in CSF and effects on neurotransmitter synthesis  
  Miller L, Insel T, Scheinin M, Aloi J, Murphy DL, Linnoila M, Lovenberg W, Neurochem Res, 1/1/1986
• A comparison between the GH response to amphetamine and clonidine  
  Siever LJ, Insel TR, Hamilton JA, Aloi JA, Murphy DL, Psych Res, 1/1/1985
• Plasma cortisol and catecholamine response to ICV administration of CRF to Rhesus monkeys  
  Insel TR, Aloi JA, Goldstein D, Wood JH, and Jimmerson DC, Life Sciences, 1/1/1984
• Neuroendocrine and behavioral effects of mCPP administration in Rhesus monkeys  
  Aloi JA, Insel TR, Mueller EA, and Murphy DL, Life Sciences, 1/1/1984
• A benzodiazepine receptor-mediated model of anxiety: Studies in non-human primates and clinical implications  
  Insel TR, Ninan PT, Aloi JA, Skolnik P, Jimmerson DC, and Paul S, Arch Gen Psychiatry, 1/1/1984
• Growth hormone response to clonidine in obsessive-compulsive patients  
  Siever LJ, Insel TR, Jimmerson DC, Lake CR, Uhde TW, Aloi J, and Murphy DL, Br J Psychiatry, 1/1/1983
• Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls  
  Siever LJ, Uhde TW, Silberman EK, Jimmerson DC, Aloi JA, Post RM, and Murphy DL, Psyc. Res, 1/1/1982
• Join now to see all

Books/Book Chapters

• Textbook of Diabetes: A Clinical Approach. 
  Chapter: How to use Type 2 diabetes treatments in clinical practice: combination therapies. 
  Aloi, JA and McCall, ALEditors: Holt, R, Flyvbjerg A, Cockram C and Goldstein BJ.Wiley-Blackwell2010
• Diagnostic Strategies for Common Medical Problems 
  Chapter: Secondary Amenorrhea. 
  Aloi JA, Connelly JE, Philbrick JTEditors: Black ER, Bordley DR, Tape TG and Panzer RJ.American College of Physicians, Philadelphia, PAEdition 2nd,1999
• GHRH, GH, and IGF-I, Basic and Clinical Advances. 
  Chapter: Growth hormone releasing hormone and growth hormone releasing peptides. 
  Vance ML, Aloi JA, Hartman ML, Kirk SE and Thorner MOEditors: Blackman MR, Harman SM, Roth J, and Shapiro JR.Serono Symposia, USA, Norwell, MA1995
• The Somatotropic Axis of the Reproductive Process in Health and Disease. 
  Chapter: Growth hormone: A current perspective. 
  Thorner MO, Hartman ML, Silva CM, Gaylin B, Aloi JA, Kirk SE, Pezzoli SS, and Vance MLEditors: Adashi EY, and Thorner MO.Serono Symposia, USA, Norwell, MA1994
• Frontiers of Paediatric Neuroendocrinology 
  Chapter: Current status of therapy with growth hormone releasing neuropeptides. 
  Thorner MO, Hartman ML, Gaylin B, Aloi J, Kirk S, Pezzoli SS, and Vance M LBlackwell Scientific Publications, LTD1994
• Neurobiology of the Mood Disorders. 
  Chapter: Neuroendocrine abnormalities in depression: Possible cholinergic mechanisms. 
  Page 664 - 672Risch SC, Janowsky DS, Parker D, Kalin NH, Aloi JA, Cohen RR, and Murphy DLEditors: Post RM, and Ballinger JC.Williams and Wilkins Co., Baltimore, MD1984
• Biological Markers in Psychiatry and Neurology. 
  Chapter: Platelet monoamine oxidase as a biological marker in the affective disorders and alcoholism. 
  Page 123 - 136Murphy DL, Coursey RD, Haenel T, Aloi JA, and Buchsbaum, MSEditors: Usdin, E, and Hanin, I.Pergamon Press, New York, NY1982
• Biological Markers in Psychiatry and Neurology. 
  Chapter: Cholinergic-beta-endorphin hypersensitivity associated with depression. 
  Page 269 - 278Risch SC, Janowsky DS, Kalin NH, Cohen RM, Aloi JA, and Murphy DLEditors: Usdin, E and Hanin, I.Pergamon Press, New York, NY1982
• Join now to see all

Abstracts/Posters

• Sentara Prepares for VBP Measure Changes with SCIP Inf-4 by Turing to Patient Centric IV Insulin Dosing Software
  McFarland R, Chidester P, Conner S, Schriever S, Aloi J, Annual ADA Meeting, San Francisco, CA, 1/1/2014
• Sentara Health System Sees Reduction in Hypoglycemia Across 9 Hospitals in First 30 Days Using Inpatient Glycemic Management System by Glytec.
  Aloi J, McFarland R, Chidester P, Annual ADA Meeting, San Francisco, CA, 1/1/2014
• Glytec's E-Glycemic Management System in Combination with Real-time Clinical Surveillance Reduces Hypoglycemia and Improves Length of Stay in Hospitalized Patients wit...
  Aloi JA , Williams A, Booth R, Hebblewhite H, McFarland R and Bode B, AACE Meeting, Las Vegas, NV, 1/1/2014
• Sentara Health System sees Glycemic Improvements for Hospital Basal Bolus Patients using E-Glycemic Management System.
  Aloi JA, McFarland R, and Chidester P, AACE Meeting, Las Vegas, NV, 1/1/2014
• Success of a community based screening and intervention program for Type 2 Diabetes.
  Aloi JA, Ullal J, Lieb D and Hines S, AACE Meeting, Phoenix, AZ, 1/1/2013
• Successful Integration of AACE guidelines and EMR best practice alerts improves diabetes control.
  Aloi JA , Ghandi S, Harrison C, and Meads K, AACE Meeting, Phoenix, AZ, 1/1/2013
• Propylthiouracil associated vasculitis.
  Rawla M, Willard L and Aloi JA, AACE Meeting, Phoenix, AZ, 1/1/2013
• Role of a web based insulin algorithm in the Emergency Dept. management of Diabetic Ketoacidosis
  Aloi JA, McFarland R, Butt-Savage M, and Harrison C, International Diabetes Meeting, Cambridge, MA, 1/1/2012
• Improvement in Inpatient Glucometrics and reduction in hypoglycemic events with transition to Basal-Bolus therapy and intensive diabetes education of health care provi...
  Gonzalez M, Mulla C, McFarland, R, Chidester P, and Aloi JA, 21st Annual AACE Meeting, Philadelphia, PA, 1/1/2012
• Recombinant human parathyroid hormone therapy in an older patient with a gain of function mutation of the calcium sensing receptor – a case report.
  Gonzalez M, Lieb D, Aloi J, Richardson D, O'Brian J, Khardori R, and Mulla C, Annual AACE Meeting, Philadelphia, PA, 1/1/2012
• A Hearty cost for muscle mass.
  Ittan, S and Aloi, JA, Annual AACE Meeting, Philadelphia, PA, 1/1/2012
• Survival and Prognosis of a Case of Papillary Thyroid Cancer
  Arora H, Lieb D, and Aloi JA, Annual AACE Meeting, San Diego, CA, 1/1/2011
• Vitamin D and Medication Error – Rise or Fall
  Arora H, Lieb D, and Aloi JA, Annual AACE Meeting, Boston, MA, 1/1/2010
• Functional consequences of a naturally occurring mutation of type 2 melanocortin (ACTH) receptor.
  Malchoff, D. M., et al, Program of the 10th International Congress of Endocrinology, San Francisco, CA, 1/1/1996
• Regulation of LH and FSH synthesis and secretion.
  Marshall JC, Dalkin AC, Haisenler DJ, Kerrigan JK, Kirk SE, Aloi JA, Yasin M, 5th World Congress of Gynecological Endocrinology, Madonna di Campiglio, Italy, 1/1/1995
• Regulation of LH and FSH synthesis and secretion.
  Marshall JC, Dalkin AC, Haisenleder DJ, Kerrigan JR, Kirk SE, Aloi JA, and Yasin M, 4th World Congress of Gynecological Endocrinology, Antalya, Turkey, 1/1/1994
• Ovarian Activin receptor: Regulation by gonadotropins and estradiol.
  Aloi JA, Dalkin AC, Gilrain JT, and Marshall JC, ASCI/AFCR National Meeting, Baltimore, MD, 1/1/1994
• Ovarian inhibin subunit and follistatin mRNA: Regulation by gonadotropins and estradiol.
  Aloi JA, Dalkin AC, Yasin MY, and Marshal JC, Endocrine Society 76th Annual Meeting, Anaheim, CA, 1/1/1994
• L-692,429, a Substituted Benzolactam with GHRP-like activity, stimulates GH secretion in obese young men.
  Kirk SE, Aloi JA, Gertz BJ, Hartman ML, Schneider SH, Pezzoli SS, Wittreich JM, Krupa DA, and Thorner MO, Endocrine Society 75th Annual Meeting, Las Vegas, NV, 1/1/1993
• Gonadotropin Regulation of Ovarian Inhibin Subunit Gene Expression.
  Aloi JA and Dalkin AC, Endocrine Society 75th Annual Meeting, Las Vegas, NV, 1/1/1993
• GH Response to L-692,429, a Substituted Benzolactam which mimics GHRP, is greater than the response to GHRH in older persons.
  Aloi JA, Huhn WC, Gertz BJ, Hartman, ML Pezzoli SS, Wittreich JM, Krupa DA and Thorner MO, ASCI/AFCR National Meeting, 1/1/1993
• Clinical studies of GHRH and GH releasing peptides.
  Vance ML, Aloi JA, Hartman ML, Kirk SE, and Thorner MO, Serono Symposia, 1/1/1993
• Encephalitis due to Cat Scratch Disease.
  Smith SM, Aloi JA, Schain D, and Pearson RD, ACP Virginia Scientific Meeting, 1/1/1992
• Interaction of Growth Hormone Releasing Hormone and Growth Hormone Releasing Peptide in normal men.
  Aloi JA, Thorner MO, and Vance ML, AFCR National Meeting; Southern Society for Clinical Investigation; AFCR Regional Meeting, 1/1/1992
• Personality traits and MAO activity in air pilot candidates.
  Muscettola G, Gianbelluga A, Aloi JA, Casiello M, Galzemati M, Murphy DL, CINP, 1/1/1984
• Join now to see all

Lectures

• 2013 Virginia Chapter ACP Annual Meeting & Clinical Update 
  American College of Physician Executives (ACPE), Richmond, Virginia - 3/1/2013
• Who benefits and how to use: Meet the professor. 
  Houston, TX - 1/1/2012